UroGen Pharma
Earnings Surprise
Analysts estimated URGN earnings of $-0.51 per share this quarter (Q4). URGN's actual earnings were $-0.54 per share.
URGN EPS surprise of -5.37%Analysts estimated URGN earnings of $-0.85 per share this quarter (Q2). URGN's actual earnings were $-1.05 per share.
URGN EPS surprise of -23.47%Analysts estimated URGN earnings of $-0.82 per share this quarter (Q1). URGN's actual earnings were $-0.92 per share.
URGN EPS surprise of -12.75%Analysts estimated URGN earnings of $-0.73 per share this quarter (Q4). URGN's actual earnings were $-0.80 per share.
URGN EPS surprise of -8.93%Analysts estimated URGN earnings of $-0.83 per share this quarter (Q3). URGN's actual earnings were $-0.55 per share.
URGN EPS surprise of 34.01%Analysts estimated URGN earnings of $-0.85 per share this quarter (Q2). URGN's actual earnings were $-0.91 per share.
URGN EPS surprise of -7.24%Analysts estimated URGN earnings of $-0.88 per share this quarter (Q1). URGN's actual earnings were $-0.97 per share.
URGN EPS surprise of -9.82%Analysts estimated URGN earnings of $-0.86 per share this quarter (Q3). URGN's actual earnings were $-0.68 per share.
URGN EPS surprise of -21.20%